Comparative analysis of esterase activities of human, mouse, and rat blood

Bulletin of Experimental Biology and Medicine

Volumn 152, Issue 1, 2011, Pages 73-75

  Rudakova, E V ^a   Boltneva, N P ^a   Makhaeva, G F ^a  

^a INSTITUTE OF PHYSIOLOGICALLY ACTIVE COMPOUNDS   (Russian Federation)

Author keywords

Acetylcholinesterase; Blood; Butyrylcholinesterase; Carboxylesterase; Paraoxonase

Indexed keywords

ACETYLCHOLINESTERASE; ARYLDIALKYLPHOSPHATASE 1; CARBOXYLESTERASE; CHOLINESTERASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; ENZYME MECHANISM; ENZYME SPECIFICITY; ENZYME SUBSTRATE; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; MALE; MOUSE; NONHUMAN; RAT; SPECIES DIFFERENCE;

ACETYLCHOLINESTERASE; ADULT; ANIMALS; ANIMALS, OUTBRED STRAINS; ARYLDIALKYLPHOSPHATASE; BUTYRYLCHOLINESTERASE; CARBOXYLESTERASE; FEMALE; HUMANS; MALE; MICE; MIDDLE AGED; RATS; RATS, WISTAR; SPECIES SPECIFICITY;

MUS; RATTUS; RODENTIA;

EID: 84856559059     PISSN: 00074888     EISSN: 15738221     Source Type: Journal    
DOI: 10.1007/s10517-011-1457-y     Document Type: Article

References (15)

1. E. V. Rudakova, N. P. Boltneva, and G. F. Makhaeva, Proceedings of the VIII International Conference of Young Scientists and Students "Biochemical Physics" [in Russian], Moscow (2008), pp. 401-408.
2. L. M. Berry, L. Wollenberg, and Z. Zhao, Drug Metab. Lett., 3, No. 2, 70-77 (2009).
3. S. M. Chanda, S. R. Mortensen, V. C. Moser, and S. Padilla, Fundam. Appl. Toxicol., 38, No. 2, 148-157 (1997).
4. W. L. Chen, J. J. Sheets, R. J. Nolan, and J. L. Mattsson, Regul. Toxicol. Pharmacol., 29, No. 1, 15-22 (1999).
5. J. A. Crow, B. L. Middleton, A. Borazjani, et al., Biochim. Biophys. Acta, 1781, No. 10, 643-654 (2008).
6. C. De Vriese, F. Gregoire, R. Lema-Kisoka, et al., Endocrinology, 145, No. 11, 4997-5005 (2004).
7. T. L. Huang, T. Shiotsuki, T. Uematsu, et al., Pharm. Res., 13, No. 10, 1495-1500 (1996).
8. T. Imai, Drug. Metab. Pharmacokinet., 21, No. 3, 173-185 (2006).
9. B. Li, M. Sedlacek, I. Manoharan, et al., Biochem. Pharmacol., 70, No. 11, 1673-1684 (2005).
10. T. Minagawa, Y. Kohno, T. Suwa, and A. Tsuji, Ibid., 49, No. 10, 1361-1365 (1995).
11. S. Padilla, T. L. Lasseter, and D. Hunter, Methods in Molecular Medicine. Vol. 22: Neurodegeneration Methods and Protocols, Eds. J. Harry and H. A. Tolson, Totowa (1999), pp. 237-245.
12. E. S. Peeples, L. M. Schopfer, E. G. Duysen, et al., Toxicol. Sci., 83, No. 2, 303-312 (2005).
13. E. Reiner, A. Bosak, and V. Simeon-Rudolf, Arh. Hig. Rada Toksikol., 55, No. 1, 1-4 (2004).
14. K. Tuovinen, E. Kaliste-Korhonen, and O. Hanninen, Gen. Pharmacol., 29, No. 3, 333-335 (1997).
15. F. Worek, U. Mast, D. Kiderlen, et al., Clin. Chim. Acta, 288, Nos. 1-2, 73-90 (1999).